USP aspires to be a diverse, inclusive, innovative, and engaging organization that empowers and engages staff and volunteers.
USP has been building trust in medicine for over 200 years.
The goal of the PQM+ Program is to sustainably strengthen medical product quality assurance systems in low and middle-income countries.
The Toolkit is a resource that addresses areas of vulnerability in the medical product supply chain through prevention, detection, and response strategies and actions.
Addressing barriers to the development of complex generics: Understanding challenges and opportunities.
Submitted on May 31, 2019 - USP Comment Letter on “The Future of Insulin Biosimilars: Increasing Access and Facilitating the Efficient Development of Insulin Biosimilar and Interchangeable Products." Docket No. FDA-2019-N-1132.